Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Stud Alcohol Drugs ; 81(2): 284-292, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32359059

RESUMO

OBJECTIVE: Although the World Health Organization (WHO) declared alcohol a Class 1 carcinogen 30 years ago, few governments have communicated this fact to the public. We illustrate how alcohol industry groups seek to keep their customers in the dark about alcohol-related cancer risks. In Canada, a federally funded scientific study examining the introduction of cancer warning labels on containers was shut down following industry interference. We show that the industry complaints about the study had no legal merit. Of 47 WHO member countries with alcohol warning labels, only South Korea requires cancer warnings on alcohol containers. However, industry complaints, supported by sympathetic governments, helped weaken the warning labels' implementation. Ireland has legislated for cancer warnings but faces continuing legal opposition expressed through regional and global bodies. Cancer societies and the public health community have failed to counter industry pressures to minimize consumer awareness of alcohol's cancer risks. Placing cancer warnings on alcohol containers could make a pivotal difference in motivating both drinkers to consume less and regulators to introduce more effective policies to reduce the serious harms of alcohol consumption.


Assuntos
Consumo de Bebidas Alcoólicas/efeitos adversos , Bebidas Alcoólicas/efeitos adversos , Informação de Saúde ao Consumidor/normas , Governo , Indústrias/normas , Rotulagem de Produtos/normas , Consumo de Bebidas Alcoólicas/epidemiologia , Consumo de Bebidas Alcoólicas/legislação & jurisprudência , Bebidas Alcoólicas/legislação & jurisprudência , Informação de Saúde ao Consumidor/legislação & jurisprudência , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Indústrias/legislação & jurisprudência , Irlanda/epidemiologia , Rotulagem de Produtos/legislação & jurisprudência , Saúde Pública/legislação & jurisprudência , Saúde Pública/normas , República da Coreia/epidemiologia , Fatores de Risco , Comportamento Social , Organização Mundial da Saúde , Yukon/epidemiologia
2.
Inj Prev ; 25(4): 328-330, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-29735746

RESUMO

Airbnb helps hosts rent all or part of their home to guests as an alternative to traditional hospitality settings. Airbnb venues are not uniformly regulated across the USA. This study quantified the reported prevalence of fire safety and first-aid amenities in Airbnb venues in the USA. The sample includes 120 691 venues in 16 US cities. Proportions of host-reported smoke and carbon monoxide (CO) detectors, fire extinguishers and first-aid kits were calculated. The proportion of venues that reportedly contained amenities are as follows: smoke detectors 80% (n=96 087), CO detectors 57.5% (n=69 346), fire extinguishers 42% (n=50 884) and first-aid kits 36% (n=43 497). Among this sample of Airbnb venues, safety deficiencies were noted. While most venues had smoke alarms, approximately 1/2 had CO alarms and less than 1/2 reported having a fire extinguishers or first-aid kits. Local and state governments or Airbnb must implement regulations compliant with current National Fire Protection Association fire safety standards.


Assuntos
Intoxicação por Monóxido de Carbono/prevenção & controle , Informação de Saúde ao Consumidor/estatística & dados numéricos , Incêndios/prevenção & controle , Primeiros Socorros/estatística & dados numéricos , Equipamentos de Proteção/estatística & dados numéricos , Logradouros Públicos/legislação & jurisprudência , Monóxido de Carbono , Cidades/epidemiologia , Informação de Saúde ao Consumidor/legislação & jurisprudência , Habitação/classificação , Humanos , Equipamentos de Proteção/provisão & distribuição , Política Antifumo , Fumar/legislação & jurisprudência , Estados Unidos
3.
Am J Prev Med ; 48(1): 89-92, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25217818

RESUMO

BACKGROUND: In 2009, the U.S. Food and Drug Administration was required to mandate that graphic health warning labels be placed on cigarette packages and advertisements. PURPOSE: To assess public support in the U.S. for graphic health warning labels from 2007 to 2012. METHODS: Data from 17,498 respondents from 13 waves of the National Adult Tobacco Survey, a list-assisted random-digit-dial survey, were used. Overall support for graphic health warning labels, as well as support by smoking status, and by sociodemographics and smoker characteristics are estimated. Analyses were conducted in 2014. RESULTS: Since 2007, a majority of the public overall has been in favor of labels. Support increased significantly among the public overall and among non-smokers from 2007 through 2009 (p<0.001), after which it remained flat. Among smokers, support levels increased from 2007 through 2011 (p<0.001), but decreased significantly from 2011 through 2012 (p<0.001). Support was high regardless of smoking status, although among smokers, support varied by level of smoking, interest in quitting, and whether labels were seen as an important reason to quit. Support varied by sociodemographic characteristics, particularly among smokers. Younger, less-affluent, and less-educated smokers supported labels at higher levels than their counterparts. CONCLUSIONS: A majority of U.S. residents support graphic health warning labels for cigarette packs, though support among smokers declined after 2011.


Assuntos
Publicidade/legislação & jurisprudência , Atitude Frente a Saúde , Informação de Saúde ao Consumidor/legislação & jurisprudência , Rotulagem de Produtos/legislação & jurisprudência , Fumar/legislação & jurisprudência , Produtos do Tabaco/efeitos adversos , Adulto , Informação de Saúde ao Consumidor/métodos , Coleta de Dados/métodos , Regulamentação Governamental , Humanos , Opinião Pública , Fumar/efeitos adversos , Prevenção do Hábito de Fumar , Estados Unidos , United States Food and Drug Administration/legislação & jurisprudência
6.
Tob Control ; 20(1): 47-52, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21139013

RESUMO

PURPOSE: Electronic nicotine delivery systems (ENDS) purport to deliver nicotine to the lungs of smokers. Five brands of ENDS were evaluated for design features, accuracy and clarity of labelling and quality of instruction manuals and associated print material supplied with products or on manufacturers' websites. METHODS: ENDS were purchased from online vendors and analysed for various parameters. RESULTS: While the basic design of ENDS was similar across brands, specific design features varied significantly. Fluid contained in cartridge reservoirs readily leaked out of most brands, and it was difficult to assemble or disassemble ENDS without touching nicotine-containing fluid. Two brands had designs that helped lessen this problem. Labelling of cartridges was very poor; labelling of some cartridge wrappers was better than labelling of cartridges. In general, packs of replacement cartridges were better labelled than the wrappers or cartridges, but most packs lacked cartridge content and warning information, and sometimes packs had confusing information. Used cartridges contained fluid, and disposal of nicotine-containing cartridges was not adequately addressed on websites or in manuals. Orders were sometimes filled incorrectly, and safety features did not always function properly. Print and internet material often contained information or made claims for which there is currently no scientific support. CONCLUSIONS: Design flaws, lack of adequate labelling and concerns about quality control and health issues indicate that regulators should consider removing ENDS from the market until their safety can be adequately evaluated.


Assuntos
Comércio , Qualidade de Produtos para o Consumidor , Sistemas de Liberação de Medicamentos/efeitos adversos , Rotulagem de Medicamentos , Nicotina/administração & dosagem , Fumar , Comércio/legislação & jurisprudência , Informação de Saúde ao Consumidor/legislação & jurisprudência , Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Rotulagem de Medicamentos/legislação & jurisprudência , Eletrônica , Humanos , Estados Unidos
7.
J Asian Afr Stud ; 45(4): 387-405, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20715334

RESUMO

This article investigates the extent of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Disclosures (HIV/AIDSD) in online annual reports by 200 listed companies from 10 African countries for the year ending 2006. Descriptive statistics reveal a very low level of overall HIV/AIDSD practices with a mean of 6 per cent disclosure, with half (100 out of 200) of the African companies making no disclosures at all. Logistic regression analysis reveals that company size and country are highly significant predictors of any disclosure of HIV/AIDS in annual reports. Profitability is also statistically significantly associated with the extent of disclosure.


Assuntos
Síndrome da Imunodeficiência Adquirida , Relatórios Anuais como Assunto , Comércio , Revelação , HIV , Saúde Pública , Síndrome da Imunodeficiência Adquirida/etnologia , Síndrome da Imunodeficiência Adquirida/história , África/etnologia , Comércio/economia , Comércio/educação , Comércio/história , Comércio/legislação & jurisprudência , Informação de Saúde ao Consumidor/economia , Informação de Saúde ao Consumidor/história , Informação de Saúde ao Consumidor/legislação & jurisprudência , Atenção à Saúde/economia , Atenção à Saúde/história , Atenção à Saúde/legislação & jurisprudência , Revelação/história , Revelação/legislação & jurisprudência , História do Século XX , História do Século XXI , Saúde Pública/economia , Saúde Pública/educação , Saúde Pública/história , Saúde Pública/legislação & jurisprudência , Prática de Saúde Pública/economia , Prática de Saúde Pública/história , Prática de Saúde Pública/legislação & jurisprudência , Estatística como Assunto/educação , Estatística como Assunto/história
8.
J Gen Intern Med ; 25(2): 110-4, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19936845

RESUMO

BACKGROUND: The majority of states have enacted price transparency laws to allow patients to shop for care and to prevent price discrimination of the uninsured. In California, hospitals must provide a price estimate to a requesting uninsured patient and cannot bill for an amount greater than the reimbursement the hospital would receive from a government payer. OBJECTIVE: To assess the response rate of California hospitals to a patient price request and to compare the price estimates received to Medicare reimbursement. DESIGN: We sent letters to California acute-care hospitals from a fictional uninsured patient requesting an estimate for one of three common elective procedures: a laparoscopic cholecystectomy, a hysterectomy, or routine screening colonoscopy. PARTICIPANTS: Three hundred and fifty-three hospitals in California. MEASUREMENTS: Hospital response rates, difference between price estimates received, and Medicare reimbursement for equivalent procedures. RESULTS: Only 28% (98/353) of hospitals responded and their response varied in content. Of the 98 responses, 15 (15%) did not provide a quote and instead asked for more information such as the billing code, 55 (56%) provided a price estimate for hospital services only, 10 (10%) included both physician and hospital services, and 18 (18%) did not specify what was covered. The median discounted price estimate was higher than Medicare reimbursement rates for all procedures: hysterectomy ($17,403 vs. $5,569; p<0.001), cholecystectomy ($14,014 vs. $7,196; p<0.001) and colonoscopy ($2,017 vs. $216; p<0.001). CONCLUSIONS: Current California legislation fails to meet its objective of enabling uninsured patients to compare prices for hospital-based health care services.


Assuntos
Informação de Saúde ao Consumidor/legislação & jurisprudência , Atenção à Saúde/legislação & jurisprudência , Reembolso de Seguro de Saúde/legislação & jurisprudência , Pessoas sem Cobertura de Seguro de Saúde/legislação & jurisprudência , Medicare/legislação & jurisprudência , California , Informação de Saúde ao Consumidor/economia , Atenção à Saúde/economia , Gastos em Saúde/legislação & jurisprudência , Humanos , Reembolso de Seguro de Saúde/economia , Medicare/economia , Estados Unidos
11.
Optometry ; 79(1): 23-35, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18156093

RESUMO

BACKGROUND: Individuals are increasingly purchasing contact lenses over the Internet. No studies exist regarding Internet purchase of contact lenses and eye care health practices. METHODS: One hundred fifty-one college students were surveyed regarding contact lenses purchase category (doctor's office, store, Internet). Pearson chi-square analyses compared purchase category with responses regarding U.S. Food and Drug Administration (FDA) recommendations for purchasing contact lenses online. Analysis of variance compared contact lenses purchase category with the Time Pressure Scale (TPS). Also, correlation analyses compared the TPS with Internet eye-health statements. RESULTS: Contact lens purchase categories included doctor's office (43.0%), store (55.0%), and Internet (22.5%), with individuals purchasing at multiple venues. With regard to the FDA recommendations, those who purchased contact lenses at a doctor's office more often adhered to the recommendations, whereas those who purchased contact lenses at a store or the Internet did so less often. Those who purchased contact lenses over the Internet had significantly higher TPS scores. In addition, higher TPS scores were significantly correlated with various statements regarding the Internet. CONCLUSIONS: Those who purchase contact lenses via the Internet or store do not follow a number of FDA contact lenses recommendations. Also, those with higher TPS scores trust possible non-evidence-based contact lenses Internet information. Implications with regard to the Fairness to Contact Lens Consumers Act are discussed.


Assuntos
Comércio , Lentes de Contato/provisão & distribuição , Oftalmopatias/etiologia , Comportamentos Relacionados com a Saúde , Acessibilidade aos Serviços de Saúde , Internet , Adolescente , Adulto , Informação de Saúde ao Consumidor/legislação & jurisprudência , Feminino , Fidelidade a Diretrizes , Inquéritos Epidemiológicos , Humanos , Masculino , Guias de Prática Clínica como Assunto , Fatores de Risco , Estados Unidos , United States Food and Drug Administration/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA